Hybrid Coronary Revascularization in Multivessel Disease: The Ideal Strategy for Challenging Scenarios
Authors:
- Antonella TommasinoATAntonella Tommasino
- Emiliano Marco NavarraENEmiliano Marco Navarra
- Federico Dell'AQuilaFDFederico Dell'AQuila
- Camilla CianiCCCamilla Ciani
- Vincenzo FiorentiniVFVincenzo Fiorentini
- Simone AmiciziaSASimone Amicizia
- Andrea BerniABAndrea Berni
- Emanuele BarbatoEBEmanuele Barbato
- Giovanni MelinaGMGiovanni Melina
- 6 June 2024
- journal article
- review article
- Published by IMR Press in The Heart Surgery Forum
- Vol. 27 (6) , E689-E700
Abstract
The treatment of coronary artery disease (CAD) has considerably evolved over the last three decades thanks to innovations in percutaneous and surgical revascularization techniques. The demographic shift towards an aging population with complex coronary anatomy and multiple comorbidities necessitates a personalized approach. A primary challenge for Heart Teams is to integrate new strategies into their decision-making process. Hybrid coronary revascularization (HCR) combines the long-term benefits of coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI) to treat complex coronary artery disease. Selection of the ideal candidate for HCR requires careful evaluation of anatomic challenges and risk profiles. Although recent evidence demonstrates the safety and efficacy of HCR and makes it a viable alternative to conventional methods, further large-scale randomized controlled trials (RCTs) are needed to establish its role in routine practice. In this manuscript, we have provided an overview of the major advances in both percutaneous and surgical techniques. In addition, we have addressed the innovative implications of robotic-assisted minimally invasive direct coronary artery bypass (RA-MIDCAB) and described the surgical procedure and postoperative care in detail. Finally, we have outlined the key principles that guide our clinical practice in selecting the appropriate approach for hybrid coronary revascularization.Keywords
This publication has 59 references indexed in Scilit:
- Intravascular Lithotripsy for Treatment of Calcified Coronary Artery DiseaseInterventional Cardiology Clinics, 2022
- Physiology-Based RevascularizationJACC: Asia, 2021
- Percutaneous Coronary Intervention or Surgery for Unprotected Left Main DiseaseInterventional Cardiology Clinics, 2020
- Late clinical outcomes of myocardial hybrid revascularization versus coronary artery bypass grafting for complex triple‐vessel disease: Long‐term follow‐up of the randomized MERGING clinical trialCatheterization and Cardiovascular Interventions, 2020
- Intravascular Lithotripsy and Microaxial Percutaneous Left Ventricular Assist Device for Complex and High-Risk Percutaneous Coronary InterventionCanadian Journal of Cardiology, 2019
- Association of Improvement in Fractional Flow Reserve With Outcomes, Including Symptomatic Relief, After Percutaneous Coronary InterventionJAMA Cardiology, 2019
- Off-pump coronary artery bypass surgery: The long and winding roadInternational Journal of Cardiology, 2019
- Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery DiseaseThe American Journal of Cardiology, 2017
- Trends in Robotic-Assisted Coronary Artery Bypass Grafts: A Study of The Society of Thoracic Surgeons Adult Cardiac Surgery Database, 2006 to 2012The Annals of Thoracic Surgery, 2016
- Mechanisms of acute lumen gain following cutting balloon angioplasty in calcified and noncalcified lesions: An intravascular ultrasound studyCatheterization and Cardiovascular Interventions, 2002